KBR

Policy How could ‘A-BNCT’ begin clinical trials as new anticancer therapy? The “Accelerator-Boron Neutron Capture Therapy (A-BNCT)” has entered clinical trials as new anticancer therapy six months after it won approval.According to the minutes of the Cent... Kim Yun-mi 2022-12-01 4:27 PM

Pharma Roche withdrew Tecentriq’s indication for bladder cancer in US. What about Korea? Roche has withdrawn Tecentriq’s indication for bladder cancer in the United States, but experts predict its effects on patients in clinical practice will not be significant.On Nov.... Jeong Min-jun 2022-12-01 3:24 PM

Pharma Takeda Korea’s Kynteles SC wins insurance benefit Takeda Pharmaceuticals Korea said Kynteles Prefilled Pen Inj. (Kynteles SC), an inflammatory bowel disease(IBD) treatment, started to be covered by health insurance on Thursday.Kyn... Choi Hye-won 2022-12-01 2:47 PM

Special [RSNA 2022] Coreline Soft to address problems facing radiologists due to AI CHICAGO, Ill. -- Coreline Soft was one of the Korean AI companies that attracted attention by addressing the unmet needs of radiologists during the Radiological Society of North Am... Lee Han-soo 2022-11-30 5:56 PM

Policy Harassed by low medical fees, Korean doctors see their patients hurriedly Korean doctors experience low self-satisfaction and burnout, as they cannot secure adequate treatment time due to low reimbursement, a report said. It called for raising medical fe... Koh Jung Min 2022-11-30 4:46 PM

Special [RSNA 2022] 'GE Healthcare to bring about digital transformation in radiology’ CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – GE Healthcare, which is planning a spinoff from GE on the first week of January next year, showed off over 40 medic... Lee Han-soo 2022-11-30 9:27 AM

Bio Women with high diastolic BP 1.7 times riskier of breast cancer Middle-aged women with high diastolic blood pressure are 1.7 times likelier to develop breast cancer, so they need to be more careful with their usual BP control, a study said Wedn... Marianne Chang 2022-11-30 3:41 PM

Life science 7 in 10 hypertensive Koreans don’t check their BP at home A survey has found that seven out of 10 hypertension patients in Korea do not measure their blood pressure at home.It is important to know and practice the correct method to measur... Jeong Min-jun 2022-11-30 3:44 PM

Pharma Helixmith scores local license to accelerate CDMO cell gene therapies Helixmith said on Wednesday that it obtained a human cell management license from the Ministry of Food and Drug Safety (MFDS) to accelerate its contract development and manufacturi... Marianne Chang 2022-11-30 9:59 AM

Pharma Daewoong picked as best ‘digital-marketing drugmaker’ by doctors No fewer than 92 percent of Korean doctors think pharmaceutical companies’ digital marketing activities enhanced in the non-contract era help them prescribe drugs, according to a s... Jung Won-gi 2022-11-30 11:01 AM

Pharma Celltrion expects securer revenue basis with patent on RemsimaSC Celltrion said Wednesday that the company has secured a more stable basis of sales by winning patent rights for RemsimaSC, its autoimmune disease treatment, in an increasing number... Choi Hye-won 2022-11-30 2:39 PM

Hospital Experts' views vary on ‘how’ Korea should implement telemedicine Medical professionals and other healthcare experts agree on the need for Korea to introduce telemedicine but disagree on “how.”A recent survey by the National Evidence-based health... Kwak Sung-sun 2022-11-29 2:52 PM

Hospital ‘Post-pandemic medical workforce shortage will reach crisis situation’ What measures prevent the departure of exhausted medical personnel due to the prolonged Covid-19 pandemic? Is there a way to make patients who left the hospital due to Covid-19 vis... Kim Eun-young 2022-11-29 4:41 PM

Special [RSNA 2022] 'Medical IP’s AI tech covers diagnosis, prevention, and pre-surgery’ CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent -- Medical IP said it introduced new technologies to help advance the radiology industry during the Radiological Soci... Lee Han-soo 2022-11-29 11:40 AM

Pharma Handok’s 2023 turnover to drop sharply as AZ retrieves sales rights Handok will likely suffer a significant drop in turnover next year, as AstraZeneca decided to retrieve the sales rights of some rare drugs Handok introduced and marketed in Korea, ... Jeong Min-jun 2022-11-29 11:19 AM

Special [RSNA 2022] ‘Unlike other medical AI companies, Lunit to do prospective studies' CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – Lunit is well-known among the Radiological Society of North America (RSNA) community for its top-notch artificial i... Lee Han-soo 2022-11-29 4:54 PM

Policy Korea to deliver customized-ASEAN healthcare packages Health officials from ASEAN countries gathered to discuss enhancing healthcare systems with a special focus on developing universal healthcare coverage (UHC) and health security wi... Marianne Chang 2022-11-29 3:46 PM

Pharma CTC Bio teams up with Japanese firm to develop cannabidiol oral dissolving films CTC Bio said on Tuesday that it has signed a memorandum of understanding (MOU) with Co-Evolution Network LLC (CoNet LLC), a Japanese company, to develop cannabidiol (CBD) oral diss... Marianne Chang 2022-11-29 10:34 AM

Device/ICT VUNO’s AI-backed fundus reader wins nod in Taiwan VUNO, a Seoul-based medical AI solution company, said Tuesday that it won approval for VUNO Med-Fundus AI, an AI-based fundus reading device, from Taiwan’s Food and Drug Administra... Choi Hye-won 2022-11-29 1:53 PM

Pharma Will Zejula’s indication for 4th or more ovarian cancer treatments be deleted... As poly ADP-ribose polymerase (PARP) inhibitors have recently seen their indications revoked or revised in the U.S., there is also a sign of changing approval details in Zejula (ni... Kim Yun-mi 2022-11-28 1:42 PM

Hospital ‘Reimbursement criteria for CGRP-inhibiting migraine drugs not realistic’ CGRP (calcitonin gene-related peptide) inhibitors, developed to prevent adult migraines, have recently been registered on the list of insurance beneficiaries, but their reimburseme... Jeong Min-jun 2022-11-28 1:27 PM

Special [RSNA 2022] Medical device firms boast latest tech at US radiology meet CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent -- The Radiological Society of North America (RSNA) 2022 opened the world's largest radiological conference in Chicag... Lee Han-soo 2022-11-28 2:17 PM

Hospital 30% of cancer contents on social media are unproven info, a study says About 30 percent of cancer-related content on social media, including YouTube, is misinformation not verified medically, a recent study showed.A research team, led by Professor Kwo... Jung Won-gi 2022-11-28 3:57 PM

Bio Celltrion confirms RemsimaSC’s efficacy in global phase 3 trials Celltrion said Monday it proved the effectiveness and safety of RemsimaSC (pipeline name: CT-P13 SC), an autoimmune disease treatment, in two global phase 3 trials. RemsimaSC is a ... Choi Hye-won 2022-11-28 3:29 PM

Pharma GC Pharma’s Neulapeg proves effective in recurrent/refractory multiple myeloma study GC Pharma said on Monday that its neutropenia treatment, Neulapeg (ingredient: pegteograstim), confirmed effectiveness in a phase 2 study on patients with recurrent and refractory ... Marianne Chang 2022-11-28 3:13 PM

Pharma Hanmi’s US partner gives up poziotinib, shifts focus to Rolvedon Hanmi Pharmaceutical's U.S. partner, Spectrum, said that they would “deprioritize” poziotinib, its lung cancer treatment candidate, after receiving a CRL (Complete Response Letter)... Marianne Chang 2022-11-28 10:37 AM

Pharma Inventage Lab’s multiple sclerosis drug candidate to get orphan drug status Inventage Lab, a microfluidic drug delivery platform developer, said on Monday that its IVL4002, a recurrence-relieving multiple sclerosis treatment candidate, is scheduled to rece... Marianne Chang 2022-11-28 11:54 AM

Pharma Neurocritical care group eyes ‘big picture’ for next 10 years The Korean Neurocritical Care Society (KNCS) has rolled up its sleeves to prepare for treating critical neurosis patients in the future.The society aims to neurointensivits, specia... Kim Eun-young 2022-11-25 3:45 PM

Pharma Daewoong holds workshop on Fexuclue for Korean, Philippine doctors Daewoong Pharmaceutical held a symposium on Fexuclue, titled “The new wave of GERD (gastroesophageal reflux disease) Treatment,” on Thursday at its headquarters in Samseong-dong, s... Park Gi-taek 2022-11-25 4:49 PM

Opinion [Column] Dietary supplements offer no benefits People are usually sensitive to drugs’ adverse reactions rather than to their effectiveness. This is why many people turn to dietary supplements instead of medicines. Let’s take st... Jeong Jae-hoon 2022-11-25 9:35 AM

Pharma FDA hands Hanmi’s US partner, Spectrum, a poziotinib CRL to request supplementary data Spectrum Pharmaceuticals, Hanmi Pharmaceutical’s U.S. partner, said on Friday that it received a Complete Response Letter (CRL) from the FDA stating that the regulator needs supple... Marianne Chang 2022-11-25 11:34 AM

Pharma Janssen's urinary tract epithelial cancer drug ‘Balversa’ gets regulatory nod The Ministry of Food and Drug Safety approved Janssen Korea’s orphan drug, “Balversa (erdafitinib),” to treat urinary tract epithelial cancer on Thursday.Urinary tract epithelial c... Kim Chan-hyuk 2022-11-25 11:37 AM

Pharma JW Pharmaceutical OKed for phase 3 multi-country gout drug trial JW Pharmaceutical said Friday that Ministry of Food and Drug Safety(MFDS) approved a multi-country phase 3 trial of epaminurad (pipeline name: URC102), a gout treatment.Epaminurad,... Choi Hye-won 2022-11-25 2:59 PM

Pharma Qiagen Korea scores local permit for companion diagnostic of Janssen’s Balversa Qiagen Korea said on Friday it received domestic approval from the Ministry of Food and Drug Safety for Korea's first companion diagnostic (CDx) that can detect FGFR 3 (fibroblast ... Marianne Chang 2022-11-25 2:20 PM

Device/ICT Lee Min-ho, Kim Ha-neul, Jeon So-min promote 'individual beauty' with Merz... Merz Aesthetics launched its Ulthera Asia-Pacific campaign featuring three star-studded Korean actors as ambassadors to promote the pursuit of individual beauty with the aesthetic ... Marianne Chang 2022-11-25 9:35 AM

Special Eppendorf to expand its influence in Asia Eppendorf, a multinational life science company based in Germany, is renowned for systems in laboratories worldwide.The company provides a wide range of products and services requi... Lee Han-soo 2022-11-24 4:45 PM

Policy 'Not enough cancer patients get advice from medical experts' Only 44 percent of cancer patients learned cancer-related information from health experts, a study showed.The Korean Society of Medical Oncology (KSMO) and the Korean Cancer Study ... Lee Han-soo 2022-11-24 11:37 AM

Policy Korea to add Canada, Australia to drug pricing reference country list The government said it would additionally reference Canada and Australia when setting drug prices from January next year. Accordingly, the number of reference countries for drug pr... Lee Han-soo 2022-11-24 11:37 AM

Hospital Neurologists’ migraine prevalence is 8 times higher than ordinary people Nearly 50 percent of Korean neurologists experienced migraine, more than eight times higher than the estimated migraine prevalence rate of 6.0 percent among the general population,... Jung Won-gi 2022-11-24 2:17 PM

Bio MRI scans confirm long-term exposure to fine dust damages brain A team of researchers at Seoul National University Hospital together with the National Cancer Control Institute published a study that revealed brain damage from long-term air poll... Marianne Chang 2022-11-24 2:17 PM

Pharma ‘Ibuprofen and naproxen don't relieve osteoarthritis. So, reconsider... A recent study is drawing attention, as it said the long-term use of ibuprofen and naproxen, if anything, deteriorated joint inflammation and cartilage quality.The Radiological Soc... Jeong Min-jun 2022-11-24 3:59 PM

Pharma Crystal Genomics becomes largest shareholder of Pangen Biotech Crystal Genomics, a Korean biopharmaceutical firm, said Thursday it has acquired a controlling stake in Pangen Biotech."By purchasing existing shares for 20.4 billion won ($18 mill... Lee Han-soo 2022-11-24 3:14 PM

Device/ICT ATsens to supply ECG patch to Polish state hospital ATsens announced that it signed an MOU with a Polish state hospital, DCM Dolmed S.A., to supply AT-Patch, a patch-type electrocardiogram (ECG) device, to the latter.DCM Dolmed S.A.... Choi Hye-won 2022-11-24 3:33 PM

Pharma Reyon, Therabest to jointly develop pDNA sample supply business Reyon Pharmaceutical said on Thursday that it signed a memorandum of understanding (MOU) with Therabest on business cooperation based on the supply of plasmid DNA (pDNA) samples fo... Marianne Chang 2022-11-24 11:37 AM

Pharma GSK released study on severe eosinophilic asthma treatment in APSR GlaxoSmithKline (GSK) said on Wednesday that it released a study on Nucala (mepolizumab) that treats severe eosinophilic asthma in the Asia-Pacific Society for Respirology (APSR) 2... Jeong Min-jun 2022-11-24 11:42 AM

Policy ‘60% of global vaccine doses received only 5% of R&D funding’ International Vaccine Institute (IVI) Director General Jerome Kim said inequities in key areas of the vaccine industry exacerbated issues in global vaccinations.His comments came a... Marianne Chang 2022-11-23 4:26 PM

Pharma ‘Kadcyla confirmed similar effects in real-world care settings’ HER2-positive breast cancer, which accounts for 20-25 percent of breast cancer, has been known for poor treatment prognosis, as its tumor cells proliferate and metastasize actively... Kim Yun-mi 2022-11-23 4:06 PM

Pharma SK Bioscience shares plunge after suspension of Covid vaccine making SK Bioscience shares plummeted Wednesday morning after the company admitted that it had suspended production of SKYCovione, the first domestically developed Covid-19 vaccine.At 12:... Lee Han-soo 2022-11-23 1:51 PM

Pharma Boryung to launch spray-type hair loss treatment in Q1 of 2023 Boryung (formerly Boryung Pharmaceutical) is going all out for the domestic launch of Finjuve Spray, or “sprinkling Propecia,” a hair loss treatment based on finasteride.Boryung pl... Kim Chan-hyuk 2022-11-23 4:48 PM

Device/ICT Coreline's AI-based oncology contouring device wins FDA 501(k) clearance Coreline Soft, a provider of medical artificial intelligence (AI) solutions, said on Wednesday that its AI-based fully automatic contouring solution, AVIEW RT ACS, passed FDA 501 (... Marianne Chang 2022-11-23 11:02 AM

상단영역

본문영역